{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T10:33:33Z","timestamp":1782038013510,"version":"3.54.5"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,28]],"date-time":"2013-02-28T00:00:00Z","timestamp":1362009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0057830","type":"journal-article","created":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T13:41:41Z","timestamp":1362145301000},"page":"e57830","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Novel Statistical Prognostic Score Model That Includes Serum CXCL5 Levels and Clinical Classification Predicts Risk of Disease Progression and Survival of Nasopharyngeal Carcinoma Patients"],"prefix":"10.1371","volume":"8","author":[{"given":"Haibo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingna","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","article-title":"Nasopharyngeal carcinoma","volume":"365","author":"WI Wei","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/ijc.24179","article-title":"Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells","volume":"124","author":"CY Fang","year":"2009","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/onc.2009.20","article-title":"Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration","volume":"28","author":"K Endo","year":"2009","journal-title":"Oncogene"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1200\/JCO.2004.00.7542","article-title":"Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group","volume":"23","author":"AWM Lee","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijrobp.2010.03.024","article-title":"How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?","volume":"80","author":"SZ Lai","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","first-page":"505","article-title":"Long-Term Results of a Prospective Randomized Trial Comparing Neoadjuvant Chemotherapy Plus Radiotherapy with Radiotherapy Alone for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma","volume":"20","author":"J Ma","year":"2001","journal-title":"Ai Zheng"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2004.07.702","article-title":"Treatment results for nasopharyngeal carcinoma in the modern era: The Hong Kong experience","volume":"61","author":"AWM Lee","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejca.2010.09.025","article-title":"Serum CCL2 and serum TNF-\u03b1 \u2013 Two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinoma","volume":"47","author":"X Lu","year":"2011","journal-title":"Eur J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1200\/JCO.2009.25.6552","article-title":"Serologic Antienzyme Rate of Epstein-Barr Virus DNase-Specific Neutralizing Antibody Segregates TNM Classification in Nasopharyngeal Carcinoma","volume":"l28","author":"J Xu","year":"2010","journal-title":"J Clin Onco"},{"key":"ref10","first-page":"1022","article-title":"A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma","volume":"28","author":"YP Mao","year":"2009","journal-title":"Ai Zheng"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.174.6.1355","article-title":"Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8","volume":"174","author":"A Walz","year":"1991","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1172\/JCI117414","article-title":"Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis","volume":"94","author":"AE Koch","year":"1994","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/jcp.22445","article-title":"CXCL5\/ENA78 increased cell migration and epithelial-to-mesenchymal transition of hormone-independent prostate cancer by early growth response-1\/snail signaling pathway","volume":"226","author":"PL Kuo","year":"2011","journal-title":"J Cell Physiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1158\/0008-5472.CAN-05-4398","article-title":"Down-regulation of CXCL5 Inhibits Squamous Carcinogenesis","volume":"66","author":"H Miyazaki","year":"2006","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.ejca.2011.11.032","article-title":"CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer","volume":"48","author":"M Kawamura","year":"2011","journal-title":"Eur J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, <etal>et al<\/etal>.. (2012) Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology: in press.","DOI":"10.1002\/hep.25907"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2010.11.058","article-title":"Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer","volume":"178","author":"A Li","year":"2011","journal-title":"Am J Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00432-007-0225-x","article-title":"CXCL5 overexpression is associated with late classification gastric cancer","volume":"133","author":"JY Park","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1593\/neo.07976","article-title":"CXCL5 promotes prostate cancer progression","volume":"10","author":"LA Begley","year":"2008","journal-title":"Neoplasia (New York, NY)"},{"key":"ref20","first-page":"3581","article-title":"Chemokines in human colorectal carcinoma","volume":"25","author":"PK Baier","year":"2005","journal-title":"Anticancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharmthera.2006.04.002","article-title":"ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets","volume":"112","author":"C Bizzarri","year":"2006","journal-title":"Pharmacol Therapeut"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.4049\/jimmunol.175.8.5351","article-title":"The role of CXCR2\/CXCR2 ligand biological axis in renal cell carcinoma","volume":"175","author":"J Mestas","year":"2005","journal-title":"J Immunol"},{"key":"ref23","first-page":"2377","article-title":"Tumor-associated angiogenesis in prostate cancer","volume":"13","author":"T Fregene","year":"1993","journal-title":"Anticancer Res"},{"key":"ref24","first-page":"1867","article-title":"New marker for blood vessels in human ovarian and endometrial cancers","volume":"2","author":"M Samoszuk","year":"1996","journal-title":"Clin Cancer Res"},{"key":"ref25","first-page":"853","article-title":"Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer","volume":"9","author":"ES White","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0959-8049(03)00310-1","article-title":"Design of a prognostic index score for metastatic nasopharyngeal carcinoma","volume":"39","author":"YK Ong","year":"2003","journal-title":"Eur J Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/sj.bjc.6602525","article-title":"Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma","volume":"92","author":"CK Toh","year":"2005","journal-title":"Br J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejca.2011.09.004","article-title":"To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area","volume":"48","author":"Y Jin","year":"2012","journal-title":"Eur J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1748-717X-6-104","article-title":"Prognosticators and Risk Grouping in Patients with Lung Metastasis from Nasopharyngeal Carcinoma: A more accurate and appropriate assessment of prognosis","volume":"6","author":"X Cao","year":"2011","journal-title":"Radiat Oncol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ijrobp.2006.06.006","article-title":"A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy","volume":"66","author":"SH Cheng","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0057830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T07:24:26Z","timestamp":1562743466000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0057830"}},"subtitle":[],"editor":[{"given":"Goli","family":"Samimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0057830","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,28]]}}}